ADC Therapeutics SA ADCT
1.43 USD -0.17 (-10.82%)
Nov 12, 2026, 3:46 PM EST
1.42 Day range 1.56
0.96 52-week range 4.88
- YTD
- -59.58%
- 1 year
- -64.77%
ADCT revenue history
Revenue is income from the company’s ordinary business activities.
81,357,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 81,357,000 | 10,520,000 | 14.85% |
| FY 2024 | 2024-12-31 | 70,837,000 | 1,279,000 | 1.84% |
| FY 2023 | 2023-12-31 | 69,558,000 | -140,350,000 | -66.86% |
| FY 2022 | 2022-12-31 | 209,908,000 | 175,991,000 | 518.89% |
| FY 2021 | 2021-12-31 | 33,917,000 | 33,917,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | -2,340,000 | -100.00% |
| FY 2019 | 2019-12-31 | 2,340,000 | 1,200,000 | 105.26% |
| FY 2018 | 2018-12-31 | 1,140,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.